RE: VAL PYC31 Dec 2024 08:54
Val have just updated their investors , this looks very promising and VAL201 was only ever an added bonus to PYC...and a welcome one of course
Mark Eccleston, CEO of ValiRx commented "This final, time limited, extension has been granted to allow TheoremRx to complete their M&A transaction with a NASDAQ listed company, which is required to enable execution of the sub-license of VAL201 to TheoremRx. Further details on the transaction will be made public in due course